Skip to main content

New medicines advice for NHS Wales

Welsh Government has approved advice from the All Wales Medicines Strategy Group (AWMSG) for one medicine.

Buprenorphine / naloxone (Suboxone®) sublingual film is recommended for substitution treatment for opioid drug dependence. Buprenorphine/naloxone (Suboxone®) sublingual film is used in adults and adolescents over 15 years of age who have agreed to be treated for their addiction and who are also receiving medical, social and psychological support. In line with NICE guidance such treatment should be considered in patients who are unsuitable for maintenance treatment with methadone.

AWTTC’s Patient Access to Medicines Service (PAMS) supports the AWMSG to assess and monitor new medicines in Wales.